BRIEF-AB&B Says China CDE, U.S. FDA Approve IND Application Of Co's RSV Vaccine

Reuters
Aug 17
BRIEF-AB&B Says China CDE, U.S. FDA Approve IND Application Of Co's RSV Vaccine

Aug 17 (Reuters) - Ab&B Bio Tech Co Ltd JS 2627.HK:

  • SAYS CHINA CDE, U.S. FDA APPROVE INVESTIGATIONAL NEW DRUG $(IND.AU)$ APPLICATION OF CO'S RECOMBINANT RSV VACCINE

Source text

Further company coverage: 2627.HK

(Reporting by Hong Kong newsroom)

((donny.kwok@thomsonreuters.com; +852 3462 7745;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10